You are viewing the "Rob Stein | NPR" Archives
WASHINGTON, D.C. (NPR) — It’s a Wednesday morning at the National Academies of Sciences, Engineering and Medicine in downtown Washington, D.C., and Dr. Eli Adashi is opening an unprecedented gathering:… Read More
WASHINGTON (NPR) — For the first time, the Food and Drug Administration is considering allowing women to get birth control pills in the U.S. without a prescription. “It’s a very… Read More
Updated 10:30 a.m. ET WASHINGTON, D.C. (NPR) — The Food and Drug Administration is considering a major shift in the nation’s COVID-19 vaccine strategy. The goal is to simplify vaccination… Read More
PARKVILLE, Mo. (NPR) — Katie Pope Kopp went through round after round of chemotherapy and a stem cell transplant to treat her non-Hodgkin lymphoma. But nothing could beat it. “I… Read More
WASHINGTON, D.C. (NPR) — For each of the last two years, Thanksgiving helped usher in some very unwelcome guests: Devastating waves of COVID-19. No one thinks this year will be… Read More
WASHINGTON, D.C. (NPR) — Two new omicron subvariants have become dominant in the United States, raising fears they could fuel yet another surge of COVID-19 infections, according to estimates released… Read More
WASHINGTON, D.C. (NPR) — As the U.S. heads into a third pandemic winter, the first hints are emerging that another possible surge of COVID-19 infections could be on its way…. Read More
WASHINGTON, D.C. (NPR) — Has COVID-19 become no more dangerous than the flu for most people? That’s a question that scientists are debating as the country heads into a third… Read More
WASHINGTON, D.C. (NPR) — Children ages 5 through 11 who’ve received two shots of the Pfizer COVID-19 vaccine may soon be eligible for a booster. That’s if the Food and… Read More
WASHINGTON, D.C. (NPR) — As the omicron surge continues to decline in the U.S., infectious disease experts are keeping a close eye on an even more contagious version of the… Read More
WASHINGTON, D.C. (NPR) — A new analysis by the University of Washington shows the omicron surge will peak in a massive wave of infections by the end of January but… Read More
The unprecedented study involves using the gene-editing technique CRISPR to edit a gene while it’s still inside a patient’s body. In exclusive interviews, NPR talks with two of the first participants.
Daily numbers of new cases are finally starting to wane, and hospitalizations are down slightly. But health care systems are still overburdened and another resurgence remains a threat.
An antigen test could be quick, and much simpler and cheaper than the PCR tests now used to spot people infected with the novel coronavirus. But some scientists worry about an antigen test’s accuracy.
The Centers for Disease Control and Prevention is urging Americans to start to prepare for the possibility of more aggressive measures to stop the spread of the new coronavirus in the United States.
Victoria Gray, 34, of Forest, Miss., has sickle cell disease. She is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.
This could be a crucial year for the powerful gene-editing technique CRISPR as researchers start testing it in patients to treat diseases such as cancer, blindness and sickle cell disease.
Researchers think genetically engineered versions of microbes that can live in humans could help treat some rare genetic disorders and perhaps help with Type 1 diabetes, cirrhosis and cancer.
The insects were created, using CRISPR, to carry a powerful “gene drive.” The mosquitoes could provide a potent weapon against malaria, but they raise fears about unpredictable environmental effects.
Despite outrage over gene editing in China that affected the birth of twins, research is underway in the U.S. to assess the safety and effectiveness of CRISPR tools to edit genes in human embryos.
U.S. Surgeon General Jerome Adams issued a forceful advisory about vaping by U.S. teenagers, saying electronic cigarette use among young people has reached levels that require urgent action.
In its latest effort to curb smoking by young people, the FDA wants to outlaw menthol cigarettes. The agency would also restrict sales of flavored e-cigarettes to reduce youth addiction to nicotine.